ROCKET PHARMACEUTICALS, INC. Stockholders Equity

Quick Answer

ROCKET PHARMACEUTICALS, INC. reported Stockholders Equity of $277.22 million for the year ending 2025.

  • ROCKET PHARMACEUTICALS, INC. showed a decrease of -40.2% in Stockholders Equity from 2024 to 2025.
  • This data is from ROCKET PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2015: $33.95 million | Q2 2015: $31.72 million | Q3 2015: $116.48 million | Q1 2016: $99.24 million | Q2 2016: $95.44 million | Q3 2016: $85.05 million | Q1 2017: $63.26 million | Q2 2017: $57.53 million | Q3 2017: $51.08 million | Q1 2018: $170.15 million | Q2 2018: $157.08 million | Q3 2018: $143.62 million | Q1 2019: $177.08 million | Q2 2019: $248.50 million | Q3 2019: $231.92 million | Q1 2020: $286.05 million | Q2 2020: $266.52 million | Q3 2020: $241.84 million | Q1 2021: $480.00 million | Q2 2021: $489.44 million | Q3 2021: $485.66 million | Q1 2022: $417.62 million | Q2 2022: $387.70 million | Q3 2022: $367.31 million | Q1 2023: $458.88 million | Q2 2023: $402.97 million | Q3 2023: $541.09 million | Q1 2024: $441.50 million | Q2 2024: $384.64 million | Q3 2024: $329.77 million | Q1 2025: $412.14 million | Q2 2025: $354.21 million | Q3 2025: $313.67 million.
  • Over the full 13 years of available data (2013 to 2025), ROCKET PHARMACEUTICALS, INC.'s Stockholders Equity has grown by 812.7%.
  • Historical annual values: Fiscal year 2025: $277.22 million | Fiscal year 2024: $463.23 million | Fiscal year 2023: $492.57 million | Fiscal year 2022: $489.69 million | Fiscal year 2021: $454.72 million | Fiscal year 2020: $503.52 million | Fiscal year 2019: $307.30 million | Fiscal year 2018: $194.04 million | Fiscal year 2017: $15.52 million | Fiscal year 2016: $8.37 million | Fiscal year 2015: $15.54 million | Fiscal year 2014: -$51.56 million | Fiscal year 2013: -$38.90 million.
  • Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: